Welcome, please Login here
You have 0 items in your petri dish
Prozomix is employing it's GRASP™ proprietary technology in the development of novel panels of enzymes with specific applications in the field of Biocatalysis. These novel biocatalyst products, such as the Prozomix Aldo-keto reductase (ketoreductase, KRED, ADH, alcohol dehydrogenase) panel, can be purchased off-the-shelf, or acquired initially free-of-charge, via an innovative "hit fee only" based Biocatalysis Enzyme Toolkit agreement. This customer focused Applied Biocatalysis Toolkit comprises enzyme powders, expression constructs and strains. When suitable biocatalysts are identified, a comprehensive range of enzyme development and contract manufacturing solutions are available from Prozomix, catering all the way to multi-ton scale. Alternatively, the customer is free to perform the same in-house or via any third party without further reference or payment to Prozomix.
MIB Biocatalysis Event "Manchester Biocatalysis II - Bio-manufacturing the future" (Manchester, UK, May 17th, 2012)
Our Tradeshow featured our "Biocatalysis Enzyme Toolkit" concept, a new-model discovery platform that enables the synthetic chemist (in-house) to access our large and expanding multi-panel Biocatalysis Enzyme Toolkit "free-of-charge", where "hit-fees" only become owing if a useful enzyme is identified. This event also saw the launch of our innovative "kREDy-to-go" Screening Kit (ketoreductase, KRED, alcohol dehydrogenase kit), where our entire panel comprising hundreds of KREDs can be screened very cost-effectively with just the aid of a sheet of white paper! All the customer has to do is add their target chiral alcohol to each of the wells in the 96-well microplates, and visually monitor (15 min - few hours typically) the development of a deep red colour, that indicates the enzyme in that well has specificity towards the enantiomer of interest.
Prozomix offers rapid, flexible, and cost-effective off-the-shelf advanced enzyme solutions for today's fundamental and applied customer. Our products and sevices result from innovative in-house R&D activities, driven by GRASP™ proprietary technology. Our focus is the development of emerging and future enzyme technologies, such as for Biocatalysis and the Biorefinery. From a fundamental researcher looking for 1 mg of pure recombinant enzyme for a research experiment, to an industrial synthetic chemist requiring multi-ton quantities of enzyme for commercial API production, we either have the solution, or can rapidly develop one!
